Share

Beuschlein Named Editor-in-Chief of European Journal of Endocrinology

Felix Beuschlein_TAA 2024 Award Endocrine Society member and 2024 recipient of the Transatlantic Alliance Award, Felix Beuschlein, MD, has been named editor-in-chief of the European Society of Endocrinology (ESE)’s flagship journal, the European Journal of Endocrinology (EJE). He will assume his post in May 2024 when the current editor-in-chief and fellow Endocrine Society member, Wiebke Arlt, MD, DSc, FRCP,...
Share

Harnessing the Power of Professional Development

Hammes-ENDO 2022RESIZED The start of a new year offers an ideal time to reflect on our career goals and what we need to do to achieve them. As your professional home, the Endocrine Society offers a myriad of opportunities to help build your CV and advance your career. This is an ideal time to register for our...
Share

Standardized Testing: Universal Risk Stratification System Needed for Thyroid Nodules

With thyroid cancer patients often getting different — and sometimes conflicting — treatment recommendations from a variety of diagnostic tools, Priyanka Majety, MD, talks to Endocrine News about why it’s time for clinicians to coalesce around a single set of standards for these cases, which could potentially eliminate unnecessary procedures. Priyanka Majety, MD, assistant professor...
Share

Remembering John H. Nilson, PhD (1950 – 2023)

Nilson_John The research world has lost an innovator, mentor, advocate, and friend. It is with great sadness that the Endocrine Society reports that John Helmer Nilson, former editor-in-chief of Molecular Endocrinology, vice president for basic science, and recipient of the 2011 Sidney H. Ingbar Award for Distinguished Service, passed away in September while on holiday in...
Share

Pharma Fridays – January 12, 2024

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Pilot Study Announced Exploring the Effect of Oral Testosterone Therapy (CIII testosterone undecanoate capsules) on Male Fertility On January 9, Marius Pharmaceuticals, announced it has initiated a pilot study to better understand the effect of oral testosterone replacement therapy, KYZATREX® (testosterone undecanoate), on spermatogenesis...